Evidence map›Paper›PMID 23150544›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Implantable, multifunctional, bioresorbable optics.

Hu Tao, Jana M Kainerstorfer, Sean M Siebert, Eleanor M Pritchard, Angelo Sassaroli, Bruce J B Panilaitis, Mark A Brenckle, Jason J Amsden, Jonathan Levitt, Sergio Fantini and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Silk Embolic Material for Catheter-Directed Endovascular Drug Delivery.Advanced materials (Deerfield Beach, Fla.) · 2022
    Article
  4. Functionalized Mouth-Conformable Interfaces for pH Evaluation of the Oral Cavity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Programmable Vanishing Multifunctional Optics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
  10. Review
  11. Review
  12. Article
  13. Deformable and conformal silk hydrogel inverse opal.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  14. Article
  15. Article
  16. Silk-Its Mysteries, How It Is Made, and How It Is Used.ACS biomaterials science & engineering · 2015
    Article
  17. Silk-based resorbable electronic devices for remotely controlled therapy and in vivo infection abatement.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hu TaoDepartment of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.
Jana M Kainerstorfer
Sean M Siebert
Eleanor M Pritchard
Angelo Sassaroli
Bruce J B Panilaitis
Mark A Brenckle
Jason J Amsden
Jonathan Levitt
Sergio Fantini
David L Kaplan
Fiorenzo G Omenetto

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
6 · The paper itself

Abstract

Advances in personalized medicine are symbiotic with the development of novel technologies for biomedical devices. We present an approach that combines enhanced imaging of malignancies, therapeutics, and feedback about therapeutics in a single implantable, biocompatible, and resorbable device. This confluence of form and function is accomplished by capitalizing on the unique properties of silk proteins as a mechanically robust, biocompatible, optically clear biomaterial matrix that can house, stabilize, and retain the function of therapeutic components. By developing a form of high-quality microstructured optical elements, improved imaging of malignancies and of treatment monitoring can be achieved. The results demonstrate a unique family of devices for in vitro and in vivo use that provide functional biomaterials with built-in optical signal and contrast enhancement, demonstrated here with simultaneous drug delivery and feedback about drug delivery with no adverse biological effects, all while slowly degrading to regenerate native tissue.

Indexed as

Biocompatible MaterialsOptics and PhotonicsProstheses and ImplantsMetal NanoparticlesMicroscopy, Electron, ScanningBiocompatible Materials

Identifiers

PMID23150544
PMCPMC3511733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.